Crescent Capital BDC, Inc. (CCAP) Stock Price & Analysis

Crescent Capital BDC, Inc. (CCAP) is trading at USD 8.64, down 1.37% today, as of October 23, 2026 at 16:37 UTC (US market open; quotes may be delayed), according to Nexqual market data.

CCAP last closed at USD 8.76; today's session has ranged USD 8.57–8.8 on volume of 49,221 shares. Market capitalization is $318.35M, with a 52-week range of USD 8.4–15.18 (NGM). Source: Nexqual, retrieved October 23, 2026 at 16:41 UTC.

Also available as compact Markdown for AI agents: nexqual.com/CCAP.md

Key facts (CCAP)

• Insider open-market sales, last ~7 months: 6 Form 4 filings, $5.5M; 0 not under a Rule 10b5-1 plan ($0K); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
• Insider open-market purchases, last ~7 months: 4 Form 4 filings, $1.1M; 0 by opportunistic insiders, 0 by routine insiders.
• Analysts: Hold (mean 2.57 on a 1–5 scale) (7 analysts), mean target USD 11.96 (range 10–14).
• Total return with dividends: 1Y -30.6% vs S&P 500 +14.6%; 5Y -22.0% vs S&P 500 +77.3%.
• Next earnings: 2026-11-11, EPS estimate USD 0.35, revenue estimate $36.4M.

Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (CCAP)

Fiscal years end Dec. EPS is split-adjusted.

Valuation (price ÷ last four quarters, through Jun 30, 2026) (CCAP)

P/B 0.5x · Earnings yield -1.00% · Dividend yield (paid, TTM) 20.46% · Net debt $907M · EV $1.23B

P/E at fiscal year-ends: Dec 2025 15.1x, Dec 2024 9.7x, Dec 2023 7.4x.

Insider sales (SEC Form 4, open-market, last ~7 months) (CCAP)

6 of 6 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.

% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).

Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.

Insider purchases (SEC Form 4, open-market, last ~7 months) (CCAP)

4 purchases, $1.1M. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.

Analysts (CCAP)

Consensus Hold (mean 2.57 on a 1–5 scale), 7 analysts; mean target USD 11.96 (low 10, high 14).

Rating changes, last 120 days:

Total return (dividends reinvested) (CCAP)

CCAP suppliers, customers and competitors (named in its 10-K)

Quoted from the company's 10-K filed Feb 25, 2026.

CCAP company outlook (results filed Aug 10, 2026)

• “Contact: Dan McMahon daniel.mcmahon@crescentcap.com 212-364-0149 Forward-Looking Statements This press release, and other statements that Crescent BDC may make, may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act, with respect to Crescent BDC's future financial or business performance, strategies or expectations.”
• “Forward-looking statements speak only as of the date they are made, and Crescent BDC assumes no duty to and does not undertake to update forward-looking statements.”
• “(3) the impact of investments that we expect to make;”
• “(7) our expected financings and investments;”

Quoted word-for-word from the SEC 8-K results press release.

CCAP analyst estimates and revisions

CCAP options: expected move

Options price a move of about ±14.8% (±$1.30) by Dec 18, 2026, which includes earnings on Nov 11, 2026. Over the last 8 reports the stock moved ±4.6% on average.

30-day implied volatility 31.5% vs 23.7% realized over the last 30 trading days. Put/call ratio (volume) 0.25. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.

Key Statistics (as of October 23, 2026 at 16:41 UTC)

Technical Analysis (CCAP)

Nexqual's technical model rates CCAP "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of October 23, 2026 at 16:41 UTC.

Analyst Ratings (CCAP)

Wall Street analysts rate CCAP "Hold" based on 7 analysts, with a mean price target of USD 11.96 (range USD 10–14), per Nexqual as of October 23, 2026 at 16:41 UTC.

Earnings (CCAP)

Recent Earnings History

Source: Nexqual, October 23, 2026 at 16:41 UTC.

Financials & Fundamentals (CCAP)

Source: Nexqual, October 23, 2026 at 16:41 UTC.

Financial Health Score (CCAP)

Nexqual rates Crescent Capital BDC, Inc.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 16:41 UTC.

Ownership (CCAP)

Source: Nexqual, October 23, 2026 at 16:41 UTC.

Leadership (CCAP)

Crescent Capital BDC, Inc. is led by Jason A. Breaux, CEO & Chairman of the Board, per Nexqual as of October 23, 2026 at 16:41 UTC.

Major Backers & Investors (CCAP)

Notable institutional backers of Crescent Capital BDC, Inc. include Texas County & District Retirement System, Fidelity, Blackstone Inc, according to Nexqual as of October 23, 2026 at 16:41 UTC.

Active Investors

Source: Nexqual, October 23, 2026 at 16:41 UTC.

From Crescent Capital BDC, Inc.'s Latest SEC 10-K Filing (filed 2026-02-25)

Partnerships

• The Adviser has entered into a Resource Sharing Agreement (the "Resource Sharing Agreement") with Crescent, pursuant to which Crescent provides the Adviser with experienced investment professionals (including the members of the Adviser's investment committee) and access to Crescent's resources so as to enable the Adviser to fulfill its obligations under the Investment Advisory Agreement.
• On June 2, 2015, we entered into an investment advisory agreement with the Adviser which was most recently amended and restated (the "Investment Advisory Agreement") on January 5, 2021.

Legal & Regulatory Risks (Item 1A, quoted)

• We and the Adviser are subject to regulations and SEC oversight. If we or the Adviser fail to comply with applicable requirements, it may adversely impact our results relative to companies that are not subject to such regulations.
• Regulations governing our operation as a BDC affect our ability to, and the way in which we may, raise additional capital.
• New or modified laws or regulations governing our operations may adversely affect our business.
• Changes to United States tariff and import/export regulations may have a negative effect on our portfolio companies and, in turn, harm us.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 16:41 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt